Pharmaceutical Industry

Page 8 of 100

Robert F. Kennedy Jr. speaks during a campaign rally for Republican presidential nominee, former President Donald Trump at Macomb Community College in Michigan.
Politics

RFK Jr. could play a big role under Trump—and Big Pharma is sounding the alarm: ‘We need somebody grounded by science and evidence, not somebody who rejects it’

By
November 8, 2024
AstraZeneca’s China chief detained in illegal data collection and drug import probe, pharma giant says
Leadership

AstraZeneca’s China chief detained in illegal data collection and drug import probe, pharma giant says

By
November 7, 2024
Many hundred of spectators watch Queen Margrethe of Denmark while the Royal Guard takes her through the city of Kalundborg in a coach during her visit to the city where she commence a two days visit on June 13, 2017 in Kalundborg, Denmark.
Lifestyle

Danish manufacturing hub of weight-loss wonderdrug Ozempic is an epicenter for childhood overweightedness

By
November 4, 2024
Jo Natauri’s Invidia Capital seeks $850 million for first fund
Finance

Jo Natauri’s Invidia Capital seeks $850 million for first fund

By
October 31, 2024
British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance
Retail

British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance

By
October 30, 2024
A hand is seen holding Ozempic.
Health

Novo’s main Ozempic plant cited for quality lapses by FDA

By Madison Muller and Bloomberg
October 29, 2024
Top aging expert says these 4 FDA-approved drugs hold promise for extending life
Aging Well

Top aging expert says these 4 FDA-approved drugs hold promise for extending life

By
October 29, 2024
Sanofi profit lifted by early vaccine sales, dupixent growth
Finance

Sanofi profit lifted by early vaccine sales, dupixent growth

By Ashleigh Furlong, Tim Loh and Bloomberg
October 25, 2024
As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
Commentary

As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch

By Jeffrey Sonnenfeld and Steven Tian
October 24, 2024
Just 25% of people at high risk of pneumococcal disease—children younger than 2, adults older than 64, and those with certain chronic health conditions such as diabetes—have been immunized, according to an August 2024 survey by the National Foundation for Infectious Diseases.
Health

Pneumonia can be a deadly complication of COVID, the flu, and RSV: What to know about pneumococcal vaccination

By
October 22, 2024
How Merck leveled up its cybersecurity strategy since the NotPetya cyberattack that led to a $1.4 billion dispute
Leadership

How Merck leveled up its cybersecurity strategy since the NotPetya cyberattack that led to a $1.4 billion dispute

By
October 22, 2024
France's Prime Minister Michel Barnier speaking to reporters.
Health

French government ‘must block the sale’ of Sanofi’s Doliprane painkiller to U.S. private equity, critics argue

By Jurgen Hecker, Tom Barfield and AFP
October 22, 2024
Anne Wojcicki, chief executive officer and co-founder of 23andMe
Leadership

23andMe’s entire board resigned on the same day. Founder Anne Wojcicki still thinks the startup is savable

By
October 17, 2024
The world needs innovative antiviral drugs—but market incentives won’t align until it’s too late, Germany’s ‘head of challenges’ warns
Commentary

The world needs innovative antiviral drugs—but market incentives won’t align until it’s too late, Germany’s ‘head of challenges’ warns

By
October 16, 2024
Walgreens to close 1,200 stores over next three years
Health

Walgreens to close 1,200 stores over next three years

By
October 15, 2024

Most Popular